Nanosphere based oral insulin delivery

Zinc insulin is successfully encapsulated in various polyester and polyanhydride nanosphere formulations using Phase Inversion Nanoencapsulation (PIN). The encapsulated insulin maintains its biological activity and is released from the nanospheres over a span of approximately 6 h. A specific formula...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of controlled release 2000-03, Vol.65 (1), p.261-269
Hauptverfasser: Carino, Gerardo P, Jacob, Jules S, Mathiowitz, Edith
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 269
container_issue 1
container_start_page 261
container_title Journal of controlled release
container_volume 65
creator Carino, Gerardo P
Jacob, Jules S
Mathiowitz, Edith
description Zinc insulin is successfully encapsulated in various polyester and polyanhydride nanosphere formulations using Phase Inversion Nanoencapsulation (PIN). The encapsulated insulin maintains its biological activity and is released from the nanospheres over a span of approximately 6 h. A specific formulation, 1.6% zinc insulin in poly(lactide-co-glycolide) (PLGA) with fumaric anhydride oligimer and iron oxide additives has been shown to be active orally. This formulation is shown to have 11.4% of the efficacy of intraperitoneally delivered zinc insulin and is able to control plasma glucose levels when faced with a simultaneously administered glucose challenge. A number of properties of this formulation, including size, release kinetics, bioadhesiveness and ability to traverse the gastrointestinal epithelium, are likely to contribute to its oral efficacy.
doi_str_mv 10.1016/S0168-3659(99)00247-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70947678</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168365999002473</els_id><sourcerecordid>70947678</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-8aae676fc9771cf6095f92d53ba2c782dfc9829f4a89da5413493ab4cbf0d0263</originalsourceid><addsrcrecordid>eNqFkDtPwzAQgC0EoqXwE0AdUAVDwIkdOzchVPGSKhiA2XLsszBKk2I3lfrvSZsK2Fjuhvvu9RFymtKrlKbi-rULRcJEDhcAl5RmXCZsjwzTQrKEA-T7ZPiDDMhRjJ-U0pxxeUgGKRUAWSGGZPKs6yYuPjDguNQR7bgJuhr7OraVr8cWK7_CsD4mB05XEU92eUTe7-_epo_J7OXhaXo7SwwDukwKrVFI4QxImRonKOQOMpuzUmdGFpntKkUGjusCrM55yjgwXXJTOmppJtiITPq5i9B8tRiXau6jwarSNTZtVJICl0IWHZj3oAlNjAGdWgQ_12GtUqo2gtRWkNp8rwDUVpBiXd_ZbkFbztH-6eqNdMD5DtDR6MoFXRsffznGKZObOTc9hp2NlcegovFYG7Q-oFkq2_h_LvkG1MSA_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70947678</pqid></control><display><type>article</type><title>Nanosphere based oral insulin delivery</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Carino, Gerardo P ; Jacob, Jules S ; Mathiowitz, Edith</creator><creatorcontrib>Carino, Gerardo P ; Jacob, Jules S ; Mathiowitz, Edith</creatorcontrib><description>Zinc insulin is successfully encapsulated in various polyester and polyanhydride nanosphere formulations using Phase Inversion Nanoencapsulation (PIN). The encapsulated insulin maintains its biological activity and is released from the nanospheres over a span of approximately 6 h. A specific formulation, 1.6% zinc insulin in poly(lactide-co-glycolide) (PLGA) with fumaric anhydride oligimer and iron oxide additives has been shown to be active orally. This formulation is shown to have 11.4% of the efficacy of intraperitoneally delivered zinc insulin and is able to control plasma glucose levels when faced with a simultaneously administered glucose challenge. A number of properties of this formulation, including size, release kinetics, bioadhesiveness and ability to traverse the gastrointestinal epithelium, are likely to contribute to its oral efficacy.</description><identifier>ISSN: 0168-3659</identifier><identifier>EISSN: 1873-4995</identifier><identifier>DOI: 10.1016/S0168-3659(99)00247-3</identifier><identifier>PMID: 10699286</identifier><identifier>CODEN: JCREEC</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Administration, Oral ; Animals ; Area Under Curve ; Biological and medical sciences ; Blood Glucose - metabolism ; Cattle ; Diabetes ; Drug Compounding ; Drug Delivery Systems ; General and cellular metabolism. Vitamins ; General pharmacology ; Glucose Tolerance Test ; Hypoglycemic Agents - administration &amp; dosage ; Hypoglycemic Agents - blood ; Hypoglycemic Agents - pharmacology ; Injections, Intraperitoneal ; Insulin ; Insulin - administration &amp; dosage ; Insulin - blood ; Insulin - pharmacology ; Intestinal Absorption ; Medical sciences ; Microscopy, Electron, Scanning ; Microspheres ; Nanosphere ; Oral Delivery ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Polyester ; Rats</subject><ispartof>Journal of controlled release, 2000-03, Vol.65 (1), p.261-269</ispartof><rights>2000</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-8aae676fc9771cf6095f92d53ba2c782dfc9829f4a89da5413493ab4cbf0d0263</citedby><cites>FETCH-LOGICAL-c390t-8aae676fc9771cf6095f92d53ba2c782dfc9829f4a89da5413493ab4cbf0d0263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0168-3659(99)00247-3$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3550,23930,23931,25140,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1340373$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10699286$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carino, Gerardo P</creatorcontrib><creatorcontrib>Jacob, Jules S</creatorcontrib><creatorcontrib>Mathiowitz, Edith</creatorcontrib><title>Nanosphere based oral insulin delivery</title><title>Journal of controlled release</title><addtitle>J Control Release</addtitle><description>Zinc insulin is successfully encapsulated in various polyester and polyanhydride nanosphere formulations using Phase Inversion Nanoencapsulation (PIN). The encapsulated insulin maintains its biological activity and is released from the nanospheres over a span of approximately 6 h. A specific formulation, 1.6% zinc insulin in poly(lactide-co-glycolide) (PLGA) with fumaric anhydride oligimer and iron oxide additives has been shown to be active orally. This formulation is shown to have 11.4% of the efficacy of intraperitoneally delivered zinc insulin and is able to control plasma glucose levels when faced with a simultaneously administered glucose challenge. A number of properties of this formulation, including size, release kinetics, bioadhesiveness and ability to traverse the gastrointestinal epithelium, are likely to contribute to its oral efficacy.</description><subject>Administration, Oral</subject><subject>Animals</subject><subject>Area Under Curve</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose - metabolism</subject><subject>Cattle</subject><subject>Diabetes</subject><subject>Drug Compounding</subject><subject>Drug Delivery Systems</subject><subject>General and cellular metabolism. Vitamins</subject><subject>General pharmacology</subject><subject>Glucose Tolerance Test</subject><subject>Hypoglycemic Agents - administration &amp; dosage</subject><subject>Hypoglycemic Agents - blood</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Injections, Intraperitoneal</subject><subject>Insulin</subject><subject>Insulin - administration &amp; dosage</subject><subject>Insulin - blood</subject><subject>Insulin - pharmacology</subject><subject>Intestinal Absorption</subject><subject>Medical sciences</subject><subject>Microscopy, Electron, Scanning</subject><subject>Microspheres</subject><subject>Nanosphere</subject><subject>Oral Delivery</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Polyester</subject><subject>Rats</subject><issn>0168-3659</issn><issn>1873-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkDtPwzAQgC0EoqXwE0AdUAVDwIkdOzchVPGSKhiA2XLsszBKk2I3lfrvSZsK2Fjuhvvu9RFymtKrlKbi-rULRcJEDhcAl5RmXCZsjwzTQrKEA-T7ZPiDDMhRjJ-U0pxxeUgGKRUAWSGGZPKs6yYuPjDguNQR7bgJuhr7OraVr8cWK7_CsD4mB05XEU92eUTe7-_epo_J7OXhaXo7SwwDukwKrVFI4QxImRonKOQOMpuzUmdGFpntKkUGjusCrM55yjgwXXJTOmppJtiITPq5i9B8tRiXau6jwarSNTZtVJICl0IWHZj3oAlNjAGdWgQ_12GtUqo2gtRWkNp8rwDUVpBiXd_ZbkFbztH-6eqNdMD5DtDR6MoFXRsffznGKZObOTc9hp2NlcegovFYG7Q-oFkq2_h_LvkG1MSA_Q</recordid><startdate>20000301</startdate><enddate>20000301</enddate><creator>Carino, Gerardo P</creator><creator>Jacob, Jules S</creator><creator>Mathiowitz, Edith</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20000301</creationdate><title>Nanosphere based oral insulin delivery</title><author>Carino, Gerardo P ; Jacob, Jules S ; Mathiowitz, Edith</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-8aae676fc9771cf6095f92d53ba2c782dfc9829f4a89da5413493ab4cbf0d0263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Administration, Oral</topic><topic>Animals</topic><topic>Area Under Curve</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose - metabolism</topic><topic>Cattle</topic><topic>Diabetes</topic><topic>Drug Compounding</topic><topic>Drug Delivery Systems</topic><topic>General and cellular metabolism. Vitamins</topic><topic>General pharmacology</topic><topic>Glucose Tolerance Test</topic><topic>Hypoglycemic Agents - administration &amp; dosage</topic><topic>Hypoglycemic Agents - blood</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Injections, Intraperitoneal</topic><topic>Insulin</topic><topic>Insulin - administration &amp; dosage</topic><topic>Insulin - blood</topic><topic>Insulin - pharmacology</topic><topic>Intestinal Absorption</topic><topic>Medical sciences</topic><topic>Microscopy, Electron, Scanning</topic><topic>Microspheres</topic><topic>Nanosphere</topic><topic>Oral Delivery</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Polyester</topic><topic>Rats</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carino, Gerardo P</creatorcontrib><creatorcontrib>Jacob, Jules S</creatorcontrib><creatorcontrib>Mathiowitz, Edith</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of controlled release</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carino, Gerardo P</au><au>Jacob, Jules S</au><au>Mathiowitz, Edith</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nanosphere based oral insulin delivery</atitle><jtitle>Journal of controlled release</jtitle><addtitle>J Control Release</addtitle><date>2000-03-01</date><risdate>2000</risdate><volume>65</volume><issue>1</issue><spage>261</spage><epage>269</epage><pages>261-269</pages><issn>0168-3659</issn><eissn>1873-4995</eissn><coden>JCREEC</coden><abstract>Zinc insulin is successfully encapsulated in various polyester and polyanhydride nanosphere formulations using Phase Inversion Nanoencapsulation (PIN). The encapsulated insulin maintains its biological activity and is released from the nanospheres over a span of approximately 6 h. A specific formulation, 1.6% zinc insulin in poly(lactide-co-glycolide) (PLGA) with fumaric anhydride oligimer and iron oxide additives has been shown to be active orally. This formulation is shown to have 11.4% of the efficacy of intraperitoneally delivered zinc insulin and is able to control plasma glucose levels when faced with a simultaneously administered glucose challenge. A number of properties of this formulation, including size, release kinetics, bioadhesiveness and ability to traverse the gastrointestinal epithelium, are likely to contribute to its oral efficacy.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>10699286</pmid><doi>10.1016/S0168-3659(99)00247-3</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0168-3659
ispartof Journal of controlled release, 2000-03, Vol.65 (1), p.261-269
issn 0168-3659
1873-4995
language eng
recordid cdi_proquest_miscellaneous_70947678
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Administration, Oral
Animals
Area Under Curve
Biological and medical sciences
Blood Glucose - metabolism
Cattle
Diabetes
Drug Compounding
Drug Delivery Systems
General and cellular metabolism. Vitamins
General pharmacology
Glucose Tolerance Test
Hypoglycemic Agents - administration & dosage
Hypoglycemic Agents - blood
Hypoglycemic Agents - pharmacology
Injections, Intraperitoneal
Insulin
Insulin - administration & dosage
Insulin - blood
Insulin - pharmacology
Intestinal Absorption
Medical sciences
Microscopy, Electron, Scanning
Microspheres
Nanosphere
Oral Delivery
Particle Size
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Polyester
Rats
title Nanosphere based oral insulin delivery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T01%3A39%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nanosphere%20based%20oral%20insulin%20delivery&rft.jtitle=Journal%20of%20controlled%20release&rft.au=Carino,%20Gerardo%20P&rft.date=2000-03-01&rft.volume=65&rft.issue=1&rft.spage=261&rft.epage=269&rft.pages=261-269&rft.issn=0168-3659&rft.eissn=1873-4995&rft.coden=JCREEC&rft_id=info:doi/10.1016/S0168-3659(99)00247-3&rft_dat=%3Cproquest_cross%3E70947678%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70947678&rft_id=info:pmid/10699286&rft_els_id=S0168365999002473&rfr_iscdi=true